Impact of COVID-19 on cancer outcomes and disparities
Disparities in Cancer Outcomes from the COVID-19 Pandemic
This study is looking at how the COVID-19 pandemic has affected cancer screenings and diagnoses, especially for people who may not have easy access to care, to understand how these changes impact cancer outcomes and find ways to improve care for those who need it most.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Maryland Baltimore NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10890164 on NIH RePORTER |
What this research studies
This research investigates how the COVID-19 pandemic has disrupted cancer screening and diagnostic procedures, particularly among disadvantaged populations. It aims to evaluate the effects of these disruptions on cancer outcomes, including mortality rates, recurrence, and the stage at which cancers are diagnosed. By analyzing data from various health systems, the study seeks to identify at-risk populations and develop strategies to address the resulting disparities in cancer care. The research will also establish a surveillance system to monitor changes in cancer outcomes over time as the pandemic's effects evolve.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from disadvantaged backgrounds who have been affected by disruptions in cancer care due to the COVID-19 pandemic.
Not a fit: Patients who have not experienced any disruptions in their cancer care or screening processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer care strategies and reduced disparities in outcomes for vulnerable populations.
How similar studies have performed: Other research has indicated that disruptions in healthcare services can significantly impact patient outcomes, suggesting that this investigation is both timely and necessary.
Where this research is happening
Baltimore, United States
- University of Maryland Baltimore — Baltimore, United States (Active)
Researchers
- Principal investigator: Englum, Brian Robert — University of Maryland Baltimore
- Study coordinator: Englum, Brian Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.